ArticleiScience2026

An engineered hirudin-albumin prodrug enables thrombus-targeted long-acting anticoagulation with reduced bleeding risk.

Zhiyou Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.